NASDAQ:CADL

Candel Therapeutics Stock Predictions

etoro logo Buy CADL
*Your capital is at risk
$8.80
+0.380 (+4.51%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

CADL Prediction Chart

CADL Predictions History

Latest community submissions for CADL.
Predictor Target Session Target Price Result Direction Accuracy Score
Jan 22, 2025 $7.01 +5.98% $6.84 V 97.58% 1
Jan 22, 2025 $6.86 +3.71% $6.84 V 99.78% 6
Jan 22, 2025 $6.67 +0.91% $6.84 V 97.51% 1
Jan 21, 2025 $7.08 +6.18% $6.61 X 92.77% 0
Jan 21, 2025 $6.93 +3.84% $6.61 X 95.14% 0
Jan 21, 2025 Bullish $6.61 X 0
May 31, 2024 $9.20 +6.71% $8.90 V 96.64% 1
May 31, 2024 $8.98 +4.20% $8.90 V 99.08% 2
May 31, 2024 Bullish $8.90 V 1
AlexVel AlexVel Pro
May 2, 2024 $7.34 -8.02% $8.43 X 87.07% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CADL with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT CANDEL THERAPEUTICS, INC.
Candel Therapeutics
Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. The company develops CAN-2409, which is in Phase II clinical trails for the treatment of pancreatic cancer; Phase III clinical trials for the treatment of prostate cancer; and Phase II clinical trials for the treatment of lung cancer, as well as has completed Phase Ib/II clinical trials for the treatment of hi...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE